PepsiCo's International Business Shines: Can It Reignite Performance?
PepsiCo's international beverages business led the performance, achieving 11% organic growth in first-quarter 2025, driven by robust demand in key markets including China, India, Egypt, Turkey, Mexico, Brazil, the U.K. and Australia, alongside market share gains in Germany, France, Spain and South Korea. Meanwhile, the company's international convenient foods business grew 2% organically, driven by strength in markets like Brazil, Egypt, India and Turkey, and complemented by snack share gains in China, South Africa, Poland and Thailand. These results highlight the company's ability to tailor products to local preferences while strengthening market share across both beverages and snacks in a broad array of global regions.
Looking ahead, PepsiCo plans to build its global momentum by scaling its international presence and deepening its localization efforts. This includes adapting its product offerings to suit regional tastes, modifying price-pack architectures to provide greater consumer value and expanding channel reach. The company also aims to elevate productivity through investments in automation, digitalization and standardization across global operations, freeing up capital to reinvest in commercial initiatives and innovation.
PepsiCo's international growth strategy is focused on long-term profitability through sustained product innovation, market-specific customization and operational efficiency. Despite near-term headwinds from foreign exchange and supply chain inflation, particularly due to tariffs and input sourcing challenges, the company remains confident in the resilience and scalability of its global model. With a firm commitment to adaptability and efficiency, PepsiCo's international operations continue to play an essential role in supporting its broader strategic and financial goals.
PEP's Competition in the International Market
The Coca-Cola Company KO and Monster Beverage MNST are the key beverage companies competing with PepsiCo in the global arena.
Coca-Cola, a leading beverage company, is PepsiCo's key competitor in the international market. Coca-Cola and PepsiCo compete directly in several international markets, including India, China, Brazil and Mexico. In these regions, both companies vie for market share in the non-alcoholic beverage sector, employing strategies tailored to local consumer preferences and leveraging their extensive distribution networks. Coca-Cola's international strategy focuses on being a "Total Beverage Company," expanding beyond carbonated drinks to include juices, dairy, plant-based beverages and energy drinks. Regionally, Coca-Cola's market share is particularly strong in Latin America (61.8%), Western Europe (51.8%) and the Asia-Pacific region (50.9%). This dominance is attributed to its strategic localization efforts, adapting products to suit regional tastes and preferences. Coca-Cola's international business remains a critical driver of its global performance, contributing approximately 61.3% of its total revenues in 2024.
Monster Beverage's international business continues to be a key growth driver, contributing approximately 39.6% of its total revenues in the first quarter of 2025. Strategically, MNST is focused on expanding its international footprint through product launches in key markets such as China, India and the EMEA region. The development of a juice production facility in Ireland is part of its efforts to bolster growth and regional efficiencies. These initiatives aim to enhance Monster Beverage's global presence and adapt to regional consumer preferences. Monster Beverage's international operations overlap with PepsiCo's in several key markets, including China, India and Mexico. In these regions, both companies compete in the energy drink segment, with PepsiCo's Rockstar brand and MNST's diverse offerings like Reign, Bang and NOS vying for market share. This competition underscores the dynamic nature of the global energy drink market and the strategic importance of these regions for both companies.
PEP's Price Performance, Valuation and Estimates
Shares of PepsiCo have lost around 13.5% year to date against the industry's growth of 6.9%.
From a valuation standpoint, PEP trades at a forward price-to-earnings ratio of 16.33X, significantly below the industry's average of 18.59X.
The Zacks Consensus Estimate for PEP's 2025 earnings implies a year-over-year decline of 3.6%, whereas its 2026 earnings estimate suggests a year-over-year uptick of 5.4%. The estimates for 2025 and 2026 have been southbound in the past 30 days.
PEP stock currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Zacks Names #1 Semiconductor Stock
It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CocaCola Company (The) (KO): Free Stock Analysis Report
PepsiCo, Inc. (PEP): Free Stock Analysis Report
Monster Beverage Corporation (MNST): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
4 hours ago
- Globe and Mail
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad's global commercial strategy and execution, succeeding Mike Crowley, who is retiring after a distinguished 26-year career with the company. Mehta brings extensive leadership and commercial expertise in biopharmaceutical, life science research, and diagnostics markets to Bio-Rad. He joins from Labcorp, where he served as Senior Vice President, overseeing large-scale commercial operations for the company's West Division. Prior to Labcorp, Mehta was Vice President and General Manager, Applied Technologies, at Thermo Fisher Scientific. In this role, he successfully managed a global business unit serving diverse markets. Earlier in his career, Mehta held commercial roles of increasing responsibility at Dow Chemical, where he designed and executed impactful commercial growth strategies. He holds an MBA from The Wharton School at the University of Pennsylvania and a BS in Electrical Engineering from Kurkshetra University in Thanesar, India. "Rajat's proven track record in delivering above-market growth, building high-achieving teams, and driving alignment across multiple business segments will be instrumental as we continue to advance our long-term strategy,' said Jon DiVincenzo, Bio-Rad's President and Chief Operating Officer. 'His focus on commercial excellence and deep understanding of large, global organizations spanning both clinical diagnostics and life science markets make him a fantastic addition to our leadership team." Norman Schwartz, Bio-Rad's Chairman and CEO, added, "On behalf of everyone at Bio-Rad, I want to extend our deepest gratitude and acknowledgement to Mike Crowley for his exceptional service and unwavering dedication. Since joining our commercial team in 1998, and particularly during his tenure as EVP of Global Commercial Operations since 2014, Mike's leadership has been instrumental in building our global sales and services organization and contributing to Bio-Rad's overall success.' About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit Forward-Looking Statements This release may be deemed to contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements we make regarding our executive officers. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "plan", "believe," "expect," "anticipate," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions, although not all forward-looking statements contain these words. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. These risks and uncertainties include risks relating to our international operations; global economic and geopolitical conditions; tariffs or other trade barriers; reductions in government funding or capital spending of our customers; the uncertain pace of the biopharma sector's recovery; international legal and regulatory risks; our ability to develop and market new or improved products; our ability to compete effectively; foreign currency exchange fluctuations; supply chain issues; product quality and liability issues; our ability to integrate acquired companies, products or technologies into our company successfully; changes in the healthcare industry; and natural disasters and other catastrophic events beyond our control. For further information regarding our risks and uncertainties, please refer to the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operation" in Bio-Rad's public reports filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Bio-Rad cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. We disclaim any obligation to update these forward-looking statements.
Globe and Mail
6 hours ago
- Globe and Mail
Analysts lift gold price forecasts
Global trade and fiscal debt concerns are feeding into a flight to safer assets, sharpening gold's edge as a haven from risk, prompting analysts in a Reuters poll to sharply raise their forecasts. The poll of 40 analysts and traders returned a median forecast of $3,220 per troy ounce of gold for this year, up from $3,065 predicted in a poll three months ago. The 2026 estimate rose to $3,400 from $3,000. Spot gold prices are up 27% so far this year after hitting a record $3,500 per ounce in April with the U.S. and China in the midst of a full-blown trade war, triggering regular forays into safe-haven assets. 'The first half of 2025 confirmed what many of us have long believed. Gold is not just a hedge. It is a signal,' said David Russell at GoldCore, calling $4,000 a realistic target by end-2026 should worries about the U.S. fiscal situation deepen further. Uncertainty over looming trade deadlines with key U.S. partners has bolstered safe-haven gold's appeal, while fiscal concerns got inflated by the passage of Trump's 'One Big Beautiful Bill,' which nonpartisan analysts expect to add $3.3 trillion to the national debt. Gold has yet to reclaim April's record highs, and 'the short-term consolidation is set to continue as the market misses an imminent trigger to restart the rally,' said Carsten Menke, an analyst at Julius Baer. Most analysts believe that central banks remain the bedrock of gold's rally, driven by the long-term diversification of reserves away from dollar dominance. China has added to its reserves for eight months consecutively, while an ECB survey showed nearly two-fifths of central banks cite geopolitical risk as a reason to hold gold. 'The multipolar world persists and with it the central banks' desire to be less dependent on the U.S. dollar as a reserve currency and - in an extreme case - less susceptible to U.S. sanctions,' Menke said. Silver has surged 32% so far this year, outperforming gold and nearing the key $40 mark for the first time in fourteen years. Analysts lifted their 2025 silver price forecast to $34.52 from $33.10 in the previous poll, aided by worries about U.S. tariff policy, signs of tightness in the spot market and growing investor interest in alternatives to gold. The average 2026 silver price forecast was raised to $38 per ounce from $34.58. Much of the recent surge came from inflows into exchange-traded products, and if that momentum slows, silver could become vulnerable despite expectations of another market deficit this year, said Standard Chartered analyst Suki Cooper.
National Post
7 hours ago
- National Post
Nedia Fiber and Birla Cable Ltd. Form Exclusive Strategic Alliance to Boost Optical Fiber Cable Supply across the Americas
Article content ASHBURN, Va. — Nedia Fiber, a U.S.-based optical fiber cable supplier, and Birla Cable Ltd., a publicly listed global leader in fiber optic cable manufacturing, have formed a strategic alliance to accelerate the delivery of high-performance fiber optic solutions across the Americas. This alliance aims to reduce lead times, and meet growing telecom and broadband infrastructure needs across the region. Article content Nedia Fiber brings decades of expertise and understanding of the American market. With a focus on speed, responsiveness, and execution, the company is positioning itself as a leading supplier for ISPs, Telcos, and EPCs across the Americas. Birla Cable Ltd., part of the esteemed M.P. Birla Group, is one of India's most respected fiber optic manufacturers, offering a portfolio of fiber and cable products supported by cutting-edge production facilities and global certifications. Article content 'We are excited to launch this important alliance with Birla Cable Ltd., a company known worldwide for its manufacturing strength and product excellence,' said Mr. Siby Pothen, President of Nedia Fiber. 'Together, we are building a responsive supply model that aligns with the infrastructure needs of our customers across the Americas.' Article content 'This important alliance is a key step in our global growth strategy,' said Mr. R. Sridharan, CEO of Birla Cable Ltd. 'Working with Nedia Fiber gives us direct access to the American market, backed by a team that understands how to move quickly, serve locally, and scale effectively.' Article content Mr. Luiz Fuschini, COO of Nedia Fiber, added: 'Our alliance with Birla Cable is about execution. We are enabling the market with inventory flowing into the U.S. and strategic locations in South America. With a committed supply chain, we are ready to support projects with speed, precision, and trust. This is a bold step forward for both companies and for the industry across the Americas.' Article content About Nedia Fiber Article content Nedia Fiber provides agile, customer-focused optical fiber cable supply solutions throughout the Americas. The company delivers fiber solutions with speed, technical support, and reliable execution. Article content About Birla Cable Ltd. Article content Birla Cable Ltd., part of the M.P. Birla Group, is a leading Indian manufacturer of optical fiber and cables. Publicly listed and globally recognized, operates with its state-of-the-art production facilities and a commitment to technological innovation and product excellence. Article content Article content Article content Article content Article content Article content
